Stocks › BIIB

BIOGEN INC.

BIIB·Nasdaq·United States United States·USD
$249.59
+2.46 (+1.00%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
BIIB
BIOGEN INC. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
BIIBS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of BIIB by members of U.S. Congress · 223 on record · 16 in the last 12 months
All congressional trades →
PoliticianStockTypeFiledTraded
Ro KhannaRo KhannaHouse · D · CA BIIBBIOGEN INC. · Common Stock Purchase
$1,001 - $15,000
Oct 8, 2026 Sep 4, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA BIIBBIOGEN INC. · Stock Sale
$1,001 - $15,000
Oct 8, 2026 Sep 11, 2026 Filing ↗
Maria Elvira SalazarMaria Elvira SalazarHouse · R · FL BIIBBIOGEN INC. · Stock Sale
$1,001 - $15,000
Oct 7, 2026 Sep 24, 2026 Filing ↗
Kevin HernKevin HernHouse · R · OK BIIBBIOGEN INC. · Stock Sale
$1,001 - $15,000
Sep 1, 2026 Aug 18, 2026 Filing ↗
Alan ArmstrongAlan ArmstrongSenate · R · OK BIIBBIOGEN INC. · Stock Purchase
$1,001 - $15,000
Jul 21, 2026 Mar 27, 2026 Filing ↗
Maria Elvira SalazarMaria Elvira SalazarHouse · R · FL BIIBBIOGEN INC. · Stock Sale
$15,001 - $50,000
Jul 7, 2026 Jun 2, 2026 Filing ↗
Gilbert Ray Cisneros, Jr.Gilbert Ray Cisneros, Jr.House · D · CA BIIBBIOGEN INC. · Stock Purchase
$1,001 - $15,000
Jul 2, 2026 Jun 5, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA BIIBBIOGEN INC. · Stock Sale
$1,001 - $15,000
Jun 10, 2026 May 27, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA BIIBBIOGEN INC. · Stock Purchase
$1,001 - $15,000
Jun 10, 2026 May 15, 2026 Filing ↗
Maria Elvira SalazarMaria Elvira SalazarHouse · R · FL BIIBBIOGEN INC. · Stock Purchase
$50,001 - $100,000
Jun 8, 2026 May 11, 2026 Filing ↗
Maria Elvira SalazarMaria Elvira SalazarHouse · R · FL BIIBBIOGEN INC. · Stock Purchase
$1,001 - $15,000
Jun 8, 2026 May 12, 2026 Filing ↗
Maria Elvira SalazarMaria Elvira SalazarHouse · R · FL BIIBBIOGEN INC. · Stock Purchase
$1,001 - $15,000
Jun 8, 2026 May 11, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA BIIBBIOGEN INC. · Common Stock Sale
$1,001 - $15,000
May 11, 2026 Apr 13, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA BIIBBIOGEN INC. · Common Stock Sale
$1,001 - $15,000
Mar 9, 2026 Feb 6, 2026 Filing ↗
Gilbert Ray Cisneros, Jr.Gilbert Ray Cisneros, Jr.House · D · CA BIIBBIOGEN INC. · Stock Purchase
$1,001 - $15,000
Feb 13, 2026 Jan 30, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA BIIBBIOGEN INC. · Stock Purchase
$1,001 - $15,000
Feb 6, 2026 Jan 29, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA BIIBBIOGEN INC. · Common Stock Purchase
$1,001 - $15,000
Sep 9, 2025 Aug 26, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA BIIBBIOGEN INC. · Stock Sale
$1,001 - $15,000
Jun 10, 2025 May 19, 2025 Filing ↗
Robert P. Bresnahan, Jr.Robert P. Bresnahan, Jr.House · R · PA BIIBBIOGEN INC. · Stock Purchase
$1,001 - $15,000
Jun 9, 2025 May 15, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA BIIBBIOGEN INC. · Common Stock Purchase
$1,001 - $15,000
May 12, 2025 Apr 23, 2025 Filing ↗
Robert P. Bresnahan, Jr.Robert P. Bresnahan, Jr.House · R · PA BIIBBIOGEN INC. · Stock Sale
$1,001 - $15,000
May 8, 2025 Apr 8, 2025 Filing ↗
Robert P. Bresnahan, Jr.Robert P. Bresnahan, Jr.House · R · PA BIIBBIOGEN INC. · Stock Purchase
$1,001 - $15,000
Mar 27, 2025 Feb 25, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA BIIBBIOGEN INC. · Common Stock Purchase
$1,001 - $15,000
Mar 6, 2025 Feb 25, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA BIIBBIOGEN INC. · Common Stock Sale
$1,001 - $15,000
Mar 6, 2025 Feb 19, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA BIIBBIOGEN INC. · Common Stock Sale
$1,001 - $15,000
Feb 6, 2025 Jan 17, 2025 Filing ↗

Whale Activity

Position changes in BIIB reported for 2026-09-30 by 1129 institutional filers
Increased: 403New: 94Held: 190Decreased: 321Closed: 65No prior filing: 56
  • Increased403
  • New94
  • Held190
  • Decreased321
  • Closed65
  • No prior filing56
FilerSharesValueChange
FMR LLC16.8M$3.79Bdecreased
BlackRock, Inc.16.1M$3.63Bincreased
PRIMECAP MANAGEMENT CO/CA/15.2M$3.43Bincreased
VANGUARD CAPITAL MANAGEMENT LLC9.7M$2.18Bincreased
STATE STREET CORP7.6M$1.71Bincreased
VANGUARD PORTFOLIO MANAGEMENT LLC6.6M$1.48Bdecreased
GEODE CAPITAL MANAGEMENT, LLC4.5M$1.01Bincreased
WELLINGTON MANAGEMENT GROUP LLP3.5M$781.3Mincreased
MORGAN STANLEY2.5M$566.1Mincreased
JPMORGAN CHASE & CO2.0M$463.0Mincreased
Invesco Ltd.2.0M$445.6Mincreased
CITADEL ADVISORS LLC1.6M$359.6Mincreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by BIIB insiders, by quarter · Form 4
-10.0K-5,00005,00010.0K2025 Q1: -8,7602025 Q12025 Q2: -2,5712025 Q22025 Q3: -2,7402025 Q32025 Q4: 02025 Q42026 Q1: -3,4052026 Q12026 Q2: 02026 Q22026 Q3: -1,1862026 Q32026 Q4: 02026 Q4

Recent Insider Transactions

3,337 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Minor LloydDirector Sale −593 $200.96 $119K Aug 4, 2026 Form 4 ↗
Minor LloydDirector Sale −593 $203.34 $121K Aug 3, 2026 Form 4 ↗
HAWKINS WILLIAM ADirector Grant / award +1,505 $0.00 $0 Jun 9, 2026 Form 4 ↗
SHERWIN STEPHEN ADirector Grant / award +1,505 $0.00 $0 Jun 9, 2026 Form 4 ↗
Rowinsky Eric KDirector Grant / award +1,505 $0.00 $0 Jun 9, 2026 Form 4 ↗
Mantas Jesus BDirector Grant / award +1,505 $0.00 $0 Jun 9, 2026 Form 4 ↗
LANGER SUSANDirector Grant / award +1,505 $0.00 $0 Jun 9, 2026 Form 4 ↗
Patolawala Monish DDirector Grant / award +1,505 $0.00 $0 Jun 9, 2026 Form 4 ↗
Pangalos Menelas NDirector Grant / award +1,505 $0.00 $0 Jun 9, 2026 Form 4 ↗
Pangalos Menelas NDirector Option exercise +2,370 $0.00 $0 Jun 9, 2026 Form 4 ↗
Minor LloydDirector Grant / award +1,505 $0.00 $0 Jun 9, 2026 Form 4 ↗
Freire Maria CDirector Grant / award +2,005 $0.00 $0 Jun 9, 2026 Form 4 ↗
Keeney AdamHead of Corporate Development Tax withholding −455 $187.06 $85K May 1, 2026 Form 4 ↗
Keeney AdamHead of Corporate Development Option exercise +939 $0.00 $0 May 1, 2026 Form 4 ↗
Godbout SeanChief Accounting Officer Tax withholding −54 $183.78 $10K Apr 1, 2026 Form 4 ↗
Godbout SeanChief Accounting Officer Option exercise +181 $0.00 $0 Apr 1, 2026 Form 4 ↗
Murphy NicoleHead of Pharm Ops and Tech Purchase +3 $195.04 $585 Feb 12, 2026 Form 4 ↗
Singhal PriyaHead of Development Sale −2,660 $199.83 $532K Feb 9, 2026 Form 4 ↗
Viehbacher ChristopherPresident and CEO · Director Tax withholding −6,624 $201.18 $1.3M Feb 6, 2026 Form 4 ↗
Viehbacher ChristopherPresident and CEO · Director Option exercise +15.5K $0.00 $0 Feb 6, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding BIIB · SEC Form N-PORT
FundSharesValue% of fundAs of
VANGUARD PRIMECAP FUND
VANGUARD CHESTER FUNDS
8.4M$1.81B1.88%Jun 30, 2026
Fidelity Contrafund5.0M$1.08B0.60%Jun 30, 2026
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
4.7M$1.01B0.04%Jun 30, 2026
VANGUARD 500 INDEX FUND
VANGUARD INDEX FUNDS
3.8M$827.0M0.05%Jun 30, 2026
VANGUARD MID-CAP INDEX FUND
VANGUARD INDEX FUNDS
3.2M$691.2M0.31%Jun 30, 2026
VANGUARD CAPITAL OPPORTUNITY FUND
VANGUARD HORIZON FUNDS
2.6M$567.0M1.73%Jun 30, 2026
VANGUARD HEALTH CARE FUND
VANGUARD SPECIALIZED FUNDS
2.7M$557.2M1.46%Jul 31, 2026
iShares Core S&P 500 ETF
iShares Trust
2.0M$438.8M0.05%Jun 30, 2026
Fidelity 500 Index Fund
Fidelity Concord Street Trust
1.9M$415.2M0.05%Aug 31, 2026
State Street(R) SPDR(R) S&P 500(R) ETF Trust1.8M$387.1M0.05%Jun 30, 2026

Mutual funds and ETFs whose N-PORT filings list BIIB's shares (CUSIP 09062X103), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • STATE STREET CORPORATIONSCHEDULE 13G · passive (13G) · 7.6M shares5.1%
    Nov 10, 2026 · ↗
  • Abigail P. JohnsonSCHEDULE 13G/A · passive (13G) · 18.3M shares12.4%
    Aug 6, 2026 · ↗
  • FMR LLCSCHEDULE 13G/A · passive (13G) · 18.3M shares12.4%
    Aug 6, 2026 · ↗
  • Abigail P. JohnsonSCHEDULE 13G/A · passive (13G) · 16.7M shares11.3%
    Jun 5, 2026 · ↗
  • FMR LLCSCHEDULE 13G/A · passive (13G) · 16.7M shares11.3%
    Jun 5, 2026 · ↗
  • Abigail P. JohnsonSCHEDULE 13G/A · passive (13G) · 12.8M shares8.7%
    May 6, 2026 · ↗
  • FMR LLCSCHEDULE 13G/A · passive (13G) · 12.8M shares8.7%
    May 6, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming biogen as client
$0$2.5M$5.0M$7.5M$10.0M2023 Q1: $1.2M2023 Q2: $1.8M2023 Q3: $1.3M2023 Q4: $1.1M20232024 Q1: $1.2M2024 Q2: $1.8M2024 Q3: $910K2024 Q4: $1.0M20242025 Q1: $1.2M2025 Q2: $1.6M2025 Q3: $1.2M2025 Q4: $1.0M20252026 Q1: $1.6M2026 Q2: $1.2M2026 Q3: $1.0M2026
  • FEDERAL STREET STRATEGIES, LLCBIOGEN, INC. · 2026 Q3 · HCR, MMM$50K
    Filing ↗
  • DLA PIPER LLP (US)BIOGEN, INC. · 2026 Q3 · HCR, MED, TAX, TRD$60K
    Filing ↗
  • BIOGENBIOGEN · 2026 Q3 · HCR, MMM, PHA, TAX$880K
    Filing ↗
  • TODD STRATEGY GROUPBIOGEN, INC. · 2026 Q3 · HCR, PHA$50K
    Filing ↗
  • FEDERAL STREET STRATEGIES, LLCBIOGEN, INC. · 2026 Q2 · HCR, MMM$50K
    Filing ↗

Government Contracts

Federal awards to BIOGEN INC. · USAspending

No federal contract awards found for BIOGEN INC..

U.S. Patents

Recent USPTO applications naming BIOGEN INC.

No USPTO patent applications found for BIOGEN INC..

Annual Financials

From BIIB's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Revenue$9.89B$9.68B$9.84B$10.17B$10.98B
Operating incomen/an/an/an/a$2.84B
Net income$1.29B$1.63B$1.16B$3.05B$1.56B
Diluted EPS$8.79$11.18$7.97$20.87$10.40
Operating cash flow$2.20B$2.88B$1.55B$1.38B$3.64B
Total assets$29.44B$28.05B$26.84B$24.55B$23.88B
Total liabilities$11.18B$11.33B$12.05B$11.17B$12.92B
Shareholders' equityn/an/a$14.80B$13.40B$10.90B

As BIOGEN INC. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 6, 2026 ↗

Stock Splits

Every split and reverse split in the price history
  • 3-for-1Stock splitJan 18, 2001
  • 2-for-1Stock splitDec 21, 1999

Split dates and ratios from the price history · Close Prices from Tiingo.com

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 2.02, 9.01Results of operationsOct 28, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsJul 29, 2026
    EDGAR ↗
  • 8-K · Items 2.02Results of operationsJul 1, 2026
    EDGAR ↗
  • 8-K · Items 5.07Shareholder voteJun 10, 2026
    EDGAR ↗
  • 8-K/A · Items 9.01Jun 10, 2026
    EDGAR ↗
  • 8-K · Items 1.01, 2.01, 2.03, 7.01, 9.01Material agreement · Acquisition or disposition · Direct financial obligationMay 14, 2026
    EDGAR ↗

About BIOGEN INC.

From SEC EDGAR company records
Industry (SIC 2836)Biological Products, (No Diagnostic Substances)
SectorHealthcare
HeadquartersCAMBRIDGE, MA
IncorporatedDE
Former namesBIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE